ULTRAPROCT SUPOZITOARE 0.612mg / 0.63mg / 1mg suppositories medication leaflet

C05AA08 fluocortolone pivalate + fluocortolone caproate + cinchocaine hydrochloride • Cardiovascular system | Agents for treatment of hemorrhoids and anal fissures for topical use | Corticosteroids

The combination of fluorocortolone pivalate, fluorocortolone caproate, and cinchocaine hydrochloride is used to treat inflammatory and painful conditions of the anorectal region, such as hemorrhoids, anal fissures, and other inflammations of the rectal mucosa. This combination provides anti-inflammatory, analgesic, and antipruritic effects, offering rapid symptom relief.

- Fluorocortolone pivalate and fluorocortolone caproate are corticosteroids that reduce inflammation, redness, swelling, and itching. They work by inhibiting the release of inflammatory mediators such as prostaglandins and leukotrienes and by suppressing the local immune response. The difference between the two forms of fluorocortolone lies in their duration of action: fluorocortolone pivalate has a faster onset, while fluorocortolone caproate provides prolonged action.
- Cinchocaine hydrochloride is a local anesthetic that blocks the transmission of nerve impulses, reducing pain and discomfort in the affected area. This analgesic effect contributes to the rapid relief of painful symptoms associated with anorectal conditions.

This combination is indicated for local use in the form of ointments or suppositories, depending on the location and severity of the symptoms. The treatment helps reduce inflammation and pain, facilitating healing and improving the patient's quality of life.

While effective, the use of this combination may cause some side effects, such as local irritation, burning sensations, or allergic reactions. Prolonged use of corticosteroids can lead to thinning of the skin or mucosa and an increased risk of local infections. It is important that the treatment is used short-term and as directed by a doctor.

General data about ULTRAPROCT SUPOZITOARE 0.612mg / 0.63mg / 1mg

Substance: fluocortolone pivalate + fluocortolone caproate + cinchocaine hydrochloride

Date of last drug list: 01-03-2022

Commercial code: W66060001

Concentration: 0.612mg / 0.63mg / 1mg

Pharmaceutical form: suppositories

Quantity: 10

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: BAYER HEALTHCARE MANUFACTURING S.R.L. - ITALIA

Holder: INTENDIS GMBH - GERMANIA

Number: 1410/2009/01

Shelf life: 3 years

Pharmaceutical forms available for fluocortolone pivalate + fluocortolone caproate + cinchocaine hydrochloride

Concentrations available for fluocortolone pivalate + fluocortolone caproate + cinchocaine hydrochloride

0.612mg/0.63mg/1mg, 0.918mg/0.945mg/5mg/g